Neogen Corp. Files Q3 2025 10-Q
Ticker: NEOG · Form: 10-Q · Filed: Apr 9, 2025 · CIK: 711377
| Field | Detail |
|---|---|
| Company | Neogen Corp (NEOG) |
| Form Type | 10-Q |
| Filed Date | Apr 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, earnings
TL;DR
NEOGEN Q3 2025 10-Q FILED - FINANCIALS OUT
AI Summary
Neogen Corp. filed its 10-Q for the period ending February 28, 2025, reporting on its Q3 2025 performance. The company operates in two main segments: Animal Safety and Food Safety. The filing covers financial data and operational details for the third quarter and the year-to-date period, comparing it to the prior year's performance.
Why It Matters
This filing provides investors with Neogen's latest financial results and operational updates, crucial for understanding the company's performance in the animal and food safety sectors.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags.
Key Numbers
- Q3 2025 — Fiscal Quarter (Reporting period for the 10-Q)
- 0531 — Fiscal Year End (Neogen's fiscal year concludes on May 31st)
Key Players & Entities
- NEOGEN CORP (company) — Filer of the 10-Q
- 20250228 (date) — End of the reporting period
- 0000711377 (company) — Central Index Key for NEOGEN CORP
- LANSING, MI (location) — Business and mailing address
FAQ
What were the reporting periods covered by this 10-Q filing?
This 10-Q filing covers the third quarter of fiscal year 2025, ending February 28, 2025, and compares it to the same period in the prior year (ending February 29, 2024).
What are Neogen's primary business segments?
Neogen's primary business segments are Animal Safety and Food Safety, as indicated by the segment data provided in the filing.
When does Neogen's fiscal year end?
Neogen's fiscal year ends on May 31st, as stated in the filing.
What is the filing date of this 10-Q?
This 10-Q filing was filed on April 9, 2025.
What is Neogen's SIC code?
Neogen's Standard Industrial Classification (SIC) code is 2835, which corresponds to 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES'.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on April 9, 2025 regarding NEOGEN CORP (NEOG).